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Abstract
This paper investigates historical changes in both single-year-of-age adult mortality rates and 
variation of the single-year mortality rates around expected values within age intervals over the 
past two centuries in 15 developed countries. We apply an integrated Hierarchical Age-Period-
Cohort—Variance Function Regression Model to data from the Human Mortality Database. We 
find increasing variation of the single-year rates within broader age intervals over the life course 
for all countries, but the increasing variation slows down at age 90 and then increases again after 
age 100 for some countries; the variation significantly declined across cohorts born after the early 
20th century; and the variation continuously declined over much of the last two centuries but has 
substantially increased since 1980. Our further analysis finds the recent increases in mortality 
variation are not due to increasing proportions of older adults in the population, trends in mortality 
rates, or disproportionate delays in deaths from degenerative and man-made diseases, but rather 
due to increasing variations in young and middle-age adults.
Keywords
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Introduction
Most developed countries have experienced substantial mortality declines and continuous 
life expectancy increases over the past two centuries (Oeppen and Vaupel 2002). Initial 
mortality declines resulted from decreasing mortality risks from infectious and parasitic 
diseases among young people as a result of better nutrition, hygiene, vaccines and medical 
advances. During the late 19th century and early 20th century, individuals saved from 
infectious disease-related deaths survived into middle and older ages and then faced an 
elevated risk of dying from degenerative or man-made diseases (Omran 1982), which caused 
the age-of-death distribution to progressively shift from the young to the old. Beginning in 
the late 1960s, the United States and other developed nations experienced unexpectedly 
rapid declines in mortality rates for the major degenerative diseases (e.g., heart disease, 
cancer and stroke) (Olshansky and Ault 1986), which caused the age distribution of deaths to 
further shift to the older ages (Kannisto 2001).
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This widespread demographic and epidemiologic transition has important implications for 
temporal trends in mortality dispersions, i.e., variability in age at death, measured either by 
the standard deviation around the mean or modal age of death (Cheung et al. 2005; Myers 
and Manton 1984a; Kannisto 2001), or by the distance between the lower and upper 
quartiles of the age distribution of death (“interquartile range”) (Wilmoth and Horiuchi 
1999), or by the Gini coefficient of age at death (Shkolnikov et al. 2003). Studies of 
mortality dispersion focus either on unconditional mortality dispersion (Robine 2001), i.e., 
variability of age at death across the entire life span or conditional mortality dispersion 
(Edwards and Tuljapurkar 2005; Nusselder and Mackenbach 1996; Smits and Monden 
2009), i.e., variability of age at death above certain age. Mortality dispersion has been 
viewed as an indicator of population health disparities (Edwards and Tuljapurkar 2005). 
Prior studies have found all-life-span mortality dispersion decreases over time while 
mortality dispersion at older ages is increasing (Myers and Manton 1984b), which suggests 
an increasing postponement of health disparities to older ages (Engelman et al. 2010).
Building on this prior research, the present paper examines variation in single-year-of-age-
specific mortality rates around mean rates within age intervals (e.g., age 30-40), period, and 
cohort, which we call mortality variation. This new measurement captures the variability in 
risk of death within each temporal group defined by age, period and cohort. Despite the 
difference between traditional measures of mortality dispersion and this new measure of 
mortality variation, both measures are related to variability in the risk of death within a 
population. The former tackles the variability within whole population or subpopulation 
above a certain age; the latter addresses the variability within each age group, period and 
cohort. Our approach makes two important contributions. The first is a methodological 
contribution. Prior studies calculated measures of mortality dispersion either from period or 
cohort life tables, and so were not able to simultaneously disentangle the effects of both 
factors on the trend of mortality dispersion. In this sense, our study extends and shed lights 
on the literature on mortality dispersion.
The second is a conceptual contribution. Using this approach, we are able to investigate the 
variability in risk of death not only across periods or cohorts like prior studies but also 
throughout life course which then reveals the whole picture of variability in risk of death 
across three temporal dimensions: age, period and cohort. This research is relevant to several 
research literatures; e.g., the relative contribution of mortality selection and cumulative 
advantage on the trend of health disparities across life course; the relative contribution of 
mortality selection and cohort evolution on the trend of health disparities across birth 
cohorts; and the relative contribution of mortality decline and epidemiologic transition on 
the trend of health disparities across periods. Our analyses yield some findings on the 
temporal components of mortality rates and variation that are consistent with prior research 
as well as some findings that are novel and that flow from the empirical application of the 
new statistical model. They also point to new questions and avenues for future research.
The remainder of the paper is organized as follows. The next section reviews prior research 
on historical changes in mortality rates and mortality dispersions, from which hypotheses are 
stated that embody our expectations about the age, time period, and cohort dependence of 
these rates and variation. This is followed by sections on data and methods and a 
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methodological discussion of the relationship between mortality dispersion and mortality 
variation. Findings then are presented. A discussion and conclusion section ends the paper.
Temporal Changes in Mortality Rates
The temporal dependence of mortality rates on age has been a topic of study by 
demographers since Graunt's (1662) classical study of the “Bills of Mortality” in London. 
Generally, these studies show exponentially accelerating increases in mortality rates across 
the adult ages, as embodied in Gompertz's (1825) classical law of mortality. A principal 
topic of recent research is whether the exponential increase decelerates to a plateau of high 
but stable rates at the oldest ages and, if so, at what age does the deceleration begin 
(Gavrilov and Gavrilova 2011; Vaupel 1997).
Recent studies of historical trends of mortality rates also have found patterns of cohort 
mortality declines that may have resulted from decreased exposures to physiological risk 
factors for chronic morbidities such as infection and inflammation (Finch and Crimmins 
2004), increased health capital brought about by technophysio evolution (Fogel and Costa 
1997), or a combination of these and other factors across birth cohorts (Zheng 2014). Period 
mortality declines may be attributable to a changing mix of socioeconomic development, 
lifestyle changes, and medical innovations in each period (Omran 1971; Olshansky and Ault 
1986). Systematic regression analyses that disentangle confounding time-related variables 
also suggest that, during the second half of the twentieth century, cohort effects have been 
strong while period effects have been relatively weak (Yang 2008). Nonetheless, period 
effects that impact mortality for all or most ages and cohorts are expected during wars or 
infectious disease epidemics (Omran 1982; Wilmoth 1990).
Temporal Changes in Mortality Dispersions and Their Implications on 
Mortality Variations
Prior studies of mortality dispersion examine either unconditional variability of age at death 
across the entire life span or conditional variability of age at death above certain age. Some 
scholars (Robine 2001) suggested including deaths of all age groups to calculate mortality 
dispersion and then examined all-life-span mortality dispersion over time, while others 
focused on the dependence of the trend of mortality dispersion on age. For example, Myers 
and Manton (1984a) found that all-life-span mortality dispersion in the U.S. is negatively 
correlated with the level of life expectancy, but mortality dispersion over age 60 is positively 
correlated with the level of life expectancy. These findings recently have been updated and 
extended to mortality data on 23 developed national populations with at least five decades of 
data by Engelman et al. (2010) who show that survivors to ages 75 and over have grown 
increasingly heterogeneous in their mortality risk even though all-life-span mortality 
dispersion decreases over time in these 23 countries despite some minor differences in the 
extent of mortality dispersion across countries.
There are at least two topics of theoretical interest to demographers for which measures of 
mortality dispersion are salient. One is related to the question of mortality compression and 
the limit to human life span (Caselli and Vallin 2001), and the other is related to health 
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disparities within populations. We take up the latter one and further extend the measure of 
variability of risk of death to residual mortality variation around the mean of age-specific 
mortality rates within age intervals, time periods and cohorts. As compared to prior studies 
on mortality dispersion which look exclusively at life tables where the effects of age 
structure have been removed, mortality variation in our study is affected by all three 
temporal dimensions: age, time period, and cohort. The conceptual distinction of these three 
components is essential as they are confounded with each other and affect trends in mortality 
variation. For instance, an increase in mortality variation across time periods may result 
from either cohort replacement in which cohorts with larger within-cohort mortality 
variation succeed cohorts with smaller within-cohort mortality variation or an aging society 
wherein the elderly, who usually have larger within-age mortality variation than younger 
people, increase their proportionate share in the population structure, or from some 
combination of the two. Similarly, a widening mortality variation with age may be 
confounded with other temporal patterns. That is, period patterns in mortality variation may 
affect age variability in mortality variation. And a widening mortality variation across age 
groups may also be influenced by cohort patterns.
Age Pattern in Mortality Variations
Many theoretical and empirical studies in demography, medical sociology and social 
epidemiology suggest distinct patterns of mortality variation across age, period, and cohort. 
Population heterogeneity theory conceptualizes populations as heterogeneous, composed 
with individuals or subpopulations with different physiological vulnerability to mortality or 
demographic frailty (Vaupel et al. 1979). In aggregate mortality data, frailty cannot be 
directly measured as it represents unobserved heterogeneity within populations (Vaupel et al. 
1979; Vaupel and Yashin 1985). Individual frailty is assumed to be fixed at birth and the 
mortality hazard tends to remove individuals with higher level of frailty at earlier ages. This 
leaves individuals with lower level of frailty surviving to older ages and thereby reduces the 
unobserved heterogeneity in populations at older ages. For example, Manton et al. (1981) 
found both the means and variances of frailty decreases across age groups, which is 
consistent with the operation of selective mortality across the life span. In brief, this line of 
research suggests that the convergence in health disparities and mortality variation in late 
life observed in empirical studies may be due to selective mortality. But other studies 
suggest the convergence may also result from diminished socioeconomic differences in 
exposure to risk factors, postponement of morbidity and functional limitations for higher 
socioeconomic status (SES) people, and universal biological frailty (House et al. 1994; 
House et al. 2005). Biological frailty, different from demographic frailty, has been found to 
increase over age as the capacity of the human body to resist destruction and mortality 
decreases in response to accumulated environmental stressors (Arking 2006; Strehler and 
Mildvan 1960; Zheng et al. 2011b). At the same time, cumulative advantage theory prevalent 
in medical sociology and social epidemiology argues that the advantageous status in early 
life will be accumulated and magnified across the life course, which leads to widening 
health disparities and variation in mortality risk across the life span (Lauderdale 2001; 
Lynch 2003).
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Period Pattern in Mortality Variations
In terms of change in mortality variation across time periods, current studies may also imply 
different trends. As noted, in prior studies demographers have found increasing life 
expectancy and declining mortality rates are associated with declining all-life-span mortality 
dispersion. That is, all-age-inclusive mortality dispersion in advanced human societies has 
been decreasing over time since the mid-nineteenth century when the mortality rate started 
declining due to socioeconomic development, improved nutrition, improving living 
standards, medical advances, and better public health practices. Demographic transition 
theory is echoed by epidemiologic transition theory (Olshansky and Ault 1986; Omran 
1971) which states that advanced human societies have gone through the three stages of 
transition (the age of pestilence and famine, the age of receding pandemics, and the age of 
degenerative and man-made diseases) and currently are at the fourth stage (the age of 
delayed degenerative diseases) in which advances in medical technology and health care 
programs have further delayed the age at death (Myers and Manton 1987; Olshansky and 
Ault 1986). Mortality variation declined when these degenerative diseases affected all 
population when they underwent the third stage of epidemiologic transition, but then 
increased afterwards when medical technology and health care programs started 
disproportionately benefiting higher SES groups (Glied and Lleras-Muney 2008; Lynch 
2003). As a result, in contrast to the reduced mortality dispersion based on demographic 
research, time period influences may lead to the expectation of a widening mortality 
variation in the fourth stage of epidemiologic transition. Re-emerging infectious diseases 
(Olshansky et al. 1997) may further contribute to the enlarged mortality variation in younger 
ages.
Cohort Pattern in Mortality Variations
Temporal trends of mortality variation may be dominated by period effects when the major 
causes of deaths are wars or acute infectious diseases, e.g., tuberculosis, influenza, and 
pneumonia, as these diseases affected all age groups. But when the causes of deaths shifted 
from acute to chronic diseases in the 20thcentury, cohort patterns of mortality variation may 
have emerged similarly to those found for mortality rates (Yang 2008). Similar to the two 
possible explanations of the period pattern cited above, there may exist different 
implications for mortality variation across cohorts. As overall mortality rates decrease and 
life expectancies increase, we thus may expect decreasing mortality dispersion for cohorts 
born in the 20th century (Myers and Manton 1984a). This empirical prediction is supported 
by “technophysio evolution” theory (Fogel and Costa 1997) and “cohort morbidity 
phenotype” theory (Finch and Crimmis 2004). Both theories propose that recent cohorts 
either have better initial endowment of health capital and experience slower rates of 
depreciation of health capital over age or face lessened risk factors in early life, which would 
have produced cohorts composed with more robust individuals and thereby reduce the 
mortality variation. But research on increasing health disparities across cohorts (Lynn 2003) 
implies possible increasing mortality variation across cohorts. Another unique mechanism 
contributing to cohort patterns is mortality selection. The theory of heterogeneity (Vaupel et 
al. 1979) proposes that frail members of a cohort who are more vulnerable to mortality risk 
tend to die earlier. Due to medical advances, individuals with high frailty in the later cohorts 
are more likely to survive into adulthood than those in earlier cohorts which then increases 
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the heterogeneity and subsequent mortality variation in the adulthood in later cohorts, 
especially in older ages (Engelman et al. 2010). In brief, the mortality selection mechanism 
may further contribute to increasing mortality variation across cohorts.
Hypotheses
In sum, prior demographic research leads to relatively clear predictions about how the age, 
time period, and cohort dimensions should relate to temporal trends in mortality rates. By 
comparison, there is less consensus on expectations for how these dimensions relate to 
trends in mortality dispersions. These differences are embodied in the following hypotheses:
Hypothesis 1 – Mortality Rates
We expect that temporal changes in mortality rates will show strong increases with age, and 
decreases among more recent cohorts. Period dependence will be weaker, but mortality 
increases due to wars or infectious disease epidemics will be evident.
Hypothesis 2 – Mortality Variations across Age
Cumulative advantage theory leads to the expectation that mortality variations will be 
positively related to age from young adulthood to the middle and older ages. A mortality 
selection mechanism, however, may reduce mortality variation over the life course.
Hypothesis 3 – Mortality Variations across Periods
Period effects may be present during periods of war or infectious epidemics. Decreasing 
mortality rates predict decreasing mortality variation over time, while epidemiologic 
transition theory would suggest a decreasing and then increasing mortality variation trend.
Hypothesis 4 – Mortality Variations across Cohorts
Cohort pattern should be evident across the twentieth century when the major causes of 
death shifted from acute diseases to chronic illnesses. Technophysio evolution theory and 
cohort morbidity phenotype theory predict decreasing mortality variation across cohorts, 
while the health disparities literature suggests an increasing mortality variation trend. A 
mortality selection mechanism may further contribute to increasing mortality variation 
across cohorts as weaker individuals are more likely to survive in later cohorts which 
increases the heterogeneity of population composition.
Data and Methods
Data
This study examines the variations in single-year-of-age-sex-specific mortality rates and 
mortality variations across time periods, cohorts, and age in the advanced societies. Data are 
from Human Mortality Database (http://www.mortality.org/) which includes reliable and 
complete life table and time series of data on mortality (population occurrence/exposure) 
rates. Analysis is based on 15 developed countries: Australia, Belgium, Denmark, England 
and Wales, Finland, France, Iceland, Italy, Japan, Netherlands, New Zealand, Norway, 
Sweden, Switzerland, and U.S.A. Mortality data date back to 1750 for Sweden, and to mid- 
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or late-19th century for most other countries. The data analyzed are annual, single-year-of-
age-and-period-specific mortality rates across the age range from age 18 to 109 with a final 
open-ended age 110 and over category. In total, there are 204,414 mortality rates for each of 
the male and female categories. Table 1 presents a summary of the numbers of mortality 
rates, time periods, and birth cohorts for each country in the present analysis.
Statistical Model
Prior analyses of trends in mortality levels and dispersions therein (Myers and Manton 
1984b; Engleman et al. 2010) first converted observed age-specific mortality rates into life 
tables. From the life table survivorship functions, life expectancies at various ages (e.g., ages 
0, 10, 50, 75) and single-year-age-at-death frequency distributions then were calculated, and, 
from these, standard deviations as measures of dispersions of the death frequency 
distributions around the life expectancies at the corresponding ages. Trends in the standard 
deviations then were studied by period or cohort.
The present study takes a different approach. First, we focus on the adult ages from age 18 
to the end of life. Within this age range, we partition age into intervals – the analyses 
reported here are for 10-year age intervals, but similar results are obtained for 5-year, 15-
year, or 20-year intervals. Within these age intervals and separately for each country and sex, 
we perform an integrated analysis of temporal trends in both single-year-of-age mortality 
rates and variations in those rates around expected values by applying recently developed 
Hierarchical Age-Period-Cohort-Variance Function Regression (HAPC-VFR) Models 
(Zheng et al. 2011a). This integrated regression analysis filters variability in both the single-
age mortality rates and age-specific variations of the rates around expected values within the 
age intervals into their age, period and cohort components. An integrated analysis of 
temporal trends in both mortality rates and variances has not been conducted previously due 
to the lack of a statistical model that can jointly assess the age and temporal trends of both 
mortality rates and mortality variation.
The HAPC-VFR model simultaneously assesses the effects of age, period, and cohort in the 
mean and variance of an outcome by embedding a Variance Function Regression model 
(Western and Bloome 2009) within the framework of a Hierarchical Age-Period-Cohort 
model (Yang and Land 2006). More specifically, the HAPC-VFR model is a mixed (fixed 
and random) effects model that estimates the conditional mean and conditional variance 
equations of the variance function regression model by treating the effects of age as fixed 
and those of cohorts and periods as random.1
In brief, for each of the 15 countries in the present analysis, this HAPC-VFR model is 
estimated by a two-step algorithm:
1Snijders and Bosker (1999:43-44) provide summaries of conventional statistical wisdom and methodological guidelines for choosing 
between the fixed or random specifications. They point out that if the categories are regarded as unique entities and the objective of the 
analysis is primarily to draw conclusions pertaining to each of the categories, then it is appropriate to treat the effects as fixed. On the 
other hand, if the categories are regarded as a sample from a (real or hypothetical) population and the objective of the analysis is to 
make inferences about this population, then the random coefficients model is appropriate. In the present analysis, the age range of the 
human populations analyzed is a complete listing of all possible ages, while the time periods and cohorts analyzed are only a sample 
of all possible periods and cohorts. Accordingly, the specification of the age effects as fixed and those of the periods and cohorts as 
random is consistent with conventional statistical practice.
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Step 1: Estimate the β regression coefficient vectors for between-group 
variation across age, period and cohort—We use the restricted maximum likelihood 
(REML) estimator (Raudenbush and Bryk 2002) to estimate the first step. The algebra for 
this algorithm is:
Level-1 or “Within-Cell” Model2
(1)
Level-2 or “Between-Cell” Model
(2)
for i = 1, 2, …, njk age-specific mortality rates within cohort j and period k;
j = 1, …, J birth cohorts;
k = 1, …, K time periods;
where within each birth cohort j and time period k, the single-year-of-age-specific mortality 
rate, MRijk, is modeled as a function of a set of 10-year age group dummies age18ijk, 
age30ijk, …, age100ijk, the reference age group is ages 60-69 in birth cohort j and time 
period k, and eijk is the random cell residual.
The intercept β0jk varies by birth cohort and time period. γ0 is the expected mean of 
mortality rates of the reference age group (age 60-69) averaged over all periods and cohorts; 
u0j is the residual random effect of cohort j, that is, the contribution of cohort j averaged over 
all periods, on β0jk, assumed normally distributed (Gaussian) with mean 0 and variance τu; 
and v0k is the residual random effect of period k, that is, the contribution of period k 
averaged over all cohorts, assumed normally distributed with mean 0 and variance τv. In 
addition, β0j = γ0 + u0j is the cohort MR score averaged over all periods for the reference 
age group; and β0k = γ0 + v0k is the period MR score averaged over all cohorts for the 
reference age group.
This step produces 15 sets of estimates of fixed-effects coefficients (for the age group 
dummies), random-effects (for cohorts and periods), and a random variance components 
matrix which evaluates the contributions of these age group dummies and period and cohort 
contextual variables to the explanation of variance in the conditional expected value or 
conditional mean of the outcome variable. In other words, for each of the countries, this first 
2Age-specific mortality rates are cross-classified by both the time periods and the birth cohorts. Each cell is an intersection of a cohort 
and a period.
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step regression estimates variability in the conditional mean of mortality rates across age, 
period, and cohort.
According to Hypothesis 1, we would expect that the coefficients (β1 to β8) for age groups 
to increase with age, β0j significantly declines among more recent cohorts, and β0k is 
significant and positive in periods when wars or infectious disease epidemics happened.
Step 2: Estimate the λ regression coefficient vectors for within-group 
variation across age, period, and cohort—For each country, we next calculate the 
residuals, , from the 
Step 1 regression, for each age i, and calculate the squared residuals,  or denoted as . 
We then apply the residual pseudo-likelihood (RSPL) estimator to estimate the second step. 
For normally distributed errors, the squared residuals will have a gamma distribution, and 
the second step then is estimated in generalized linear mixed model form—as a gamma 
regression of  on the age18ijk, …, age100ijk using a log link function (Western and 
Bloome 2009:300; see also Nelder and Lee 1991).
The algebra for this algorithm can be stated as follows:
Level-1 or “Within-Cell” Model
(3)
Level-2 or “Between-Cell” Model
(4)
where λ0jk is the intercept, that is, the mean log(σ2) of age-specific mortality rates of the 
reference age group (60-69) which belong to birth cohort j and time period k; π0 is the 
expected mean of log(σ2) at the reference age group (age 60-69) averaged over all periods 
and cohorts; ω0j and φ0k are the residual random effects of cohort j and period k, 
respectively, assumed normally distributed with mean 0 and variance ψω and ψφ. In 
addition, λ0j = π0 + ω0j is the cohort log(σ2) score averaged over all periods for the 
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reference age group; and λ0k = π0 + ω0k is the period log(σ2) score averaged over all 
cohorts for the reference age group.
This step produces 15 sets of estimated fixed-effects coefficients (for the age group 
dummies), random-effects (for cohorts and periods), and a random variance components 
matrix which evaluates the contributions of these variables to the explanation of variance in 
the logarithm of the residual variances . That is, for each of the 15 countries, this step 
estimates variability in the conditional variances of the mortality rates (or mortality 
variation) across age, period, and cohort.
According to Hypothesis 2, if cumulative advantage theory dominates mortality variations 
across age, the coefficients for age groups (λ1 to λ8) increase with age; if mortality selection 
is the main mechanism, the coefficients will decrease with age. According to Hypothesis 3, 
λ0k is significant and positive during periods of war or infectious epidemics. Decreasing 
mortality rates over time predict decreasing λ0k over time, while epidemiologic transition 
theory predicts a decreasing and then increasing λ0k over time. According to Hypothesis 4, 
λ0j becomes significant since the beginning of the 20th century. Technophysio evolution 
theory and cohort morbidity phenotype theory predict decreasing λ0j across cohorts; while 
the mortality selection mechanism would produce increasing λ0j across cohorts.
Even though each of these two steps produces a set of restricted maximum likelihood or 
residual pseudo-likelihood estimates for the hierarchical age-period-cohort part of the 
model, the algorithm must be iterated in order to obtain maximum likelihood (ML) 
estimators for the variance function regression model (Aitkin 1987).3 As Western and 
Bloome (2009:301) indicate, the fitted values  from an application of the twosteps 
should be saved and used in a weighted regression of MRijk on age18ijk, age30ijk, …, 
age100ijk with weights . Estimates of the residuals from Step 1 then are updated, 
Step 2 is computed, and so forth until convergence. Western and Bloome (2009:301) note 
that the ML estimator may perform poorly in small samples, in which case a REML or 
Bayes estimator can be used. In the empirical application in this study, however, the sample 
sizes are large, in which case the adjustments in the REML made for the loss of degrees of 
freedom resulting from estimation of the regression parameters will be very small, if not 
trivial. We used the SAS PROC MIXED and PROC GLIMMIX procedures to estimate the 
first- and second-step regressions, respectively.
Relation to Prior Measures of Mortality Dispersion
How do the measures of dispersions in mortality rates – estimated as age-specific residual 
variation among the single-age rates around expected values within age intervals in this 
3At Step 1 of the two-step HAPC-VFR estimation algorithm, it is assumed that the errors – the distributions of the observed single-
year-of-age mortality rates from their within-10-year-age-interval-expected values – in the regression are normally distributed. An 
examination of the empirically estimated residual distributions from application of Step 1 to the single-year-of-age mortality rates 
grouped into the 10-year age interval found them to be bell-shaped and well approximated by the normal errors specification. At Step 
2 of the estimation algorithm, the regression models are specified in terms of deviations of the observed mortality rates from those 
expected on the basis of the estimated Step 1 models. Since the estimated residuals at Step 1 are well approximated by the normal 
errors assumption, and since the squares of the normally distributed errors have a known (gamma) statistical distribution, the 
distributional assumptions of Step 2 are similarly well suited to this application.
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statistical model – relate to those used in prior studies? As a point of comparison, one of the 
most recent research contributions, Engelman et al. (2010), similarly used data from the 
Human Mortality Database. They first separately calculated period- and cohort-specific life 
tables for each of 23 national populations from which the life table age-specific functions for 
the expected number of deaths at age x, d(x), were obtained for each population. This 
calculation of the age-dependence of the distribution of deaths is similar to the statistical 
estimation of the age-interval effect coefficients in Equation (1) of our Step 1 above, except 
that the death distributions of the Engleman et al. analyses are standardized to the stationary 
population distribution of the life table.
For each age-specific distribution of deaths, any given initial age a, and any given year t, 
Engelman et al. (2010) then calculated the variance of the distribution of remaining deaths 
by averaging the squared distance of all ages at death from their mean value, the expected 
years of life remaining at age x, and then obtained estimates of the standard deviations as the 
square root of the variance. This calculation of the age-dependence of the standard 
deviations in the death distributions is similar, for the specific ages for which the 
calculations were made by Engleman et al. (2010) (ages 0, 10, 50, and 75), to the estimation 
of Equation (3) of our Step 2 above.
There are, however, three differences between the estimates of variability of Engleman et al. 
(2010) and those reported here. First, we specified the regression equations directly with the 
observed country-single-year-of-age-period-specific mortality rates as the outcome variable 
rather than the expected age-specific numbers of deaths from period-specific life tables 
calculated from the rates. Second, we estimated dispersions in mortality rates as age-specific 
residual heterogeneity among the single-age rates around expected values within age 
intervals rather than as standard deviations of life table ages of death from their expected 
values from selected ages to the end of life. Third, the analyses of Engleman et al. (2010) of 
trends in the calculated standard deviations of the life table age-at-death distributions 
proceed along either age-period or age-cohort lines, whereas our application of the HAPC-
VFR statistical model facilitates the simultaneous filtering of trends in the mortality 
variations into their age, period, and cohort components.
Findings
Variability in Mortality Rates across Age, Period, and Cohort
For the 15 countries in the present analysis, the three panels of Figure 1 display the predicted 
mortality rates based on the estimated conditional expectation functions of the HAPC model 
across the three temporal dimensions – age, period, and cohort.4 Each line represents one 
country; the same for all subsequent figures.
For both males and females, we find that the conditional means of mortality rates accelerate 
up to age 100 in all the countries, except for the U.S. (the lowest lines in the figures), where 
mortality rates increase at a lower rate after age 90. Mortality rates are very similar in young 
4For brevity, the results of estimation of the HAPC-VFR model for each of the 15 countries are presented graphically. The numerical 
estimates are available from the authors on request.
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and middle adulthoods across countries, but differences widen in older adulthood, and U.S. 
men and women have substantial lower mortality rates than other countries after age 90.
There also are strong similarities of the male and female temporal patterns in the cohort 
panels of Figure 1. Generally, the mortality rates show decreases across cohorts for all the 
countries since the early 19th century. Japan, described as an accelerated pattern of the 
classical model of epidemiological transition by Omran (1971), experienced substantial and 
rapid mortality decline beginning with the 1860 birth cohort as demonstrated by the curve 
with the steepest decline. The estimated period effects, by comparison, show no substantial 
trends in the second half of the twentieth century, after controlling for confounded age and 
cohort effects.5 Two spikes occurred in 1910-1919 and 1940-1949 due to World War I, the 
1918 influenza epidemic, and World War II; these spikes are more pronounced for males 
than females.
Overall, these findings on the age, period, and cohort dependence of changes in mortality 
rates across the twentieth century are consistent with our Hypothesis 1. Our primary focus, 
however, is on temporal changes in mortality variations, to which we now turn.
Variability in Age Interval Residual Mortality Variations across Age, Period, and Cohort
Figure 2 shows that the estimated age interval residual mortality variations increase over the 
life course for all the countries, but slow down at age 80 and increase again after age 90 for 
some countries, e.g., Japan, England, and the U.S. National differences in age interval 
residual mortality variations are small during adulthood from age 40 to 80, but are larger at 
both the lower and upper ends of the adult age range. These findings are generally similar 
for males and females.
Figure 3 portrays the variability in the estimated age interval residual mortality variations 
across cohorts. For cohorts born before the 20th century, the residual mortality variations are 
generally flat, slightly decrease, or have random variation, but there are significant declines 
across cohorts born after the early 20th century. We caution, however, that the estimated 
rapid declines in residual mortality variations in the most recent cohorts (e.g., born after 
1960) may be less statistically reliable, as these cohorts are relatively young and most of 
them have not experienced large numbers of death events yet. These findings are generally 
similar for males and females, while national differences in mortality variations across 
cohorts are relatively larger for females than for males.
Figure 4 portrays the change in estimated residual mortality variations across time periods.6 
Generally, these estimated period effects show downward trends from 1900 to 1980. These 
downward trends are interrupted by two upward spikes, more pronounced for males than 
females, during the 1910-1919 and 1940-1949 periods, indicative of the mortality impacts of 
World War I, the 1918 influenza epidemic, and World War II. In other words, in addition to 
5Most of the countries do not have data until the late-1800s. While we used all of the data to estimate the models, we do not 
substantively interpret any of the period effects estimates until at least 1900.
6The estimated residual mortality variations continuously declined from the mid-18th century in Sweden and from the mid-19th 
century in the countries for which the data series date sufficiently far back in time. The numerical estimates and figure are available 
upon request from the authors.
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increasing the expected values of mortality rates (Figure 1), these period-specific historical 
events also increased their expected variances. Also of note in Figure 4 is that, net of the age 
and cohort effects, the long-term downward trends in period effects show reversals since 
1980 in all 15 countries.
Discussion
Based on the research literature reviewed earlier, we examined several possible explanations 
for the increasing residual mortality variations in the recent decades since 1980 in all 15 
countries, including aging populations, the intrinsic relationship between mortality rates and 
mortality dispersion, and epidemiologic transition.
First, aging national populations may contribute to this phenomenon. The elderly have larger 
within-age-interval residual mortality variations than younger people; therefore increases in 
their proportionate shares in population structures will increase the residual mortality 
variations in the whole society. We created a period-level variable, the proportion of 
population age 65 and over, and entered it as an explanatory variable in the integrated 
HAPC-VFR model. As Table 2 shows, this variable has a statistically significant negative 
regression coefficient in the estimated residual mortality variation equations for both sexes 
and each of the 15 countries. In other words, for each country a time period with a larger 
proportion of population age 65 and over is associated with a smaller all-ages expected 
mortality variation, thus aging national populations do not contribute to this phenomenon. 
This is consistent with the findings of Myers and Manton (1984a) that all-life-span mortality 
dispersion is negatively correlated with the level of life expectancy, as the proportion of 
population age 65 and over is an indirect indicator of life expectancy.
Second, the recent increases in period effects on residual mortality variations (Figure 4) may 
result from either an increasing mortality rate or a declining life expectancy. Some studies 
suggest a positive relationship between mortality and mortality variation or a negative 
relationship between life expectancy and mortality variation; therefore the recent increase in 
residual mortality variation may result from increasing mortality rates or decreasing life 
expectancy. This explanation, however, is unlikely to be true, as mortality rates are relatively 
flat in recent decades, net of age and cohort effects (see the Period panels in Figure 1).
Third, a disproportionate delay in deaths from degenerative diseases may contribute to the 
increasing residual mortality variation in recent decades. From the beginning to the middle 
of the twentieth century, infectious and parasite diseases receded and degenerative diseases 
(e.g., cancer, heart diseases) became the leading causes of death for all, which narrowed the 
mortality variation. But, since 1960, public health measures and medical advances have 
especially benefited higher socioeconomic status groups, which may have led to the 
increasing mortality variation in the more recent decades. If this is true, we should observe 
an even larger increase in residual mortality variation among the elderly in recent decades as 
degenerative diseases tend to kill people at old ages. In order to test this hypothesis, we 
focus the analysis on the elderly (ages 65 and over). Figure 5 portrays trends in the estimated 
period effects for each of the 15 countries in residual mortality variation for males and 
females within this age group. Surprisingly, the estimated residual mortality variation among 
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the elderly decreased in recent decades in 14 developed countries except for the U.S. which 
experienced a large increase in residual mortality variation, especially since 1970 (the 
bolded line is the U.S.). Therefore, for most countries, a disproportionate delay in deaths 
from degenerative diseases is not the cause of the increasing residual mortality variation in 
recent decades.
Fourth, Olshansky et al. (1997) documented the re-emergence of infectious diseases (e.g., 
the Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) 
infection), which have disproportionately affected and caused deaths among people at 
different socioeconomic statuses (Rubin et al. 2009). These infectious diseases have been 
concentrated among younger people; therefore, we examine whether residual mortality 
variation among young- and middle-aged adults (ages 18 to 64) has increased in recent 
decades. Figure 6 shows that the residual mortality variation among young- and middle-aged 
adults substantially increased since 1980 in all 15 countries. It is evident from this figure that 
the period trend in residual mortality variation in recent time periods is driven by the trend 
for young- and middle-aged adults rather than for older adults, which is consistent with the 
differential age impacts of HIV/AIDS (Rubin et al. 2009).
Conclusion
We investigated historical changes in mortality rates and residual mortality variations within 
10-year age intervals across the adult ages over the past two centuries in 15 developed 
countries using an integrated HAPC-VFR Model. This model embeds a variance function 
regression model in the framework of a hierarchical age-period-cohort model. Its application 
to mortality involves two steps. In the first step, we estimated changes in mortality rates 
across the age, period, and cohort dimensions. In the second step, we estimated changes in 
residual mortality variations within age intervals across these temporal domains. Previous 
studies reported distinct age, period, and cohort components of trends in mortality rates 
(Osmond 1985; Yang 2008). The same distinctions may also apply to the trends in mortality 
variation.
Based on data from the Human Mortality Database, and consistent with prior demographic 
research, we found that, net of period and cohort effects, mortality rates accelerate across the 
adult ages among all countries. The one exception to an acceleration of the mortality rates to 
the highest age group in our analysis (100 and over years) is the U.S., where mortality rates 
increase at a slower rate after age 90 (Figure 1). With respect to this finding for the U.S., 
note that errors in age reporting may be a factor, as Gavrilov and Gavrilova (2011), using the 
more accurate age records of the Social Security Administration Death Master File, found 
no deceleration in the exponential increase in cohort mortality rates in the U.S. until after 
age 100.
We also found that men and women have substantially lower mortality rates in the U.S. than 
in other countries after age 90 (Figure 1). Similar findings were reported in Manton and 
Vaupel (1995) and Ho and Preston (2010). For example, Manton and Vaupel (1995) found 
the United States had higher life expectancy at age 80 and more favorable survival from age 
80 to 100 than Sweden, France, England and Japan. They attributed this relative advantage 
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to intensive and effective medical care among the U.S. elderly and persistent cohort effects 
of earlier conditions (e.g., relatively higher education among earlier cohorts in the U.S. than 
other countries, the healthy immigrant effect, higher mortality in young ages leaving less 
frail survivors in old ages in the U.S.) Ho and Preston (2010) also found a favorable 
mortality ranking at very old ages in the U.S. relative to other developed countries. They 
dismissed health care access (e.g., Medicare) and health behavior (e.g., smoking) as the 
major explanations for the relative advantage (Preston and Ho 2010), but attributed this to a 
more effective U.S. health care system for older patients although they could not dismiss 
mortality selection as a possible mechanism.
In addition, net of age and period effects, our analysis showed that mortality rates 
substantially declined across cohorts for all countries, while, net of age and cohort effects, 
they are relatively flat across time periods. These findings are consistent with Yang's (2008) 
conclusion, based on an age-period-cohort analysis, that mortality decline is more of a 
cohort than a period driven phenomenon. These findings also support the theory of 
technophysio evolution, which implies health capital and physiological capacities increased 
across successive cohorts (Fogel and Costa 1997). Later cohorts have been exposed to fewer 
risk factors across their life course, less inflammation in early life (Finch and Crimmins 
2004), better nutrition, better health care and public and personal health practices (Fogel 
2004), and better education (Lauderdale 2001). These advantages accumulate along life 
course and so increase life expectancy and reduce mortality risk across successive cohorts.
In our analysis of trends in residual mortality variations, we found that, net of period and 
cohort effects, these variations increase over the life course for all countries, but slow down 
at age 80 and then increase again after age 90 for some countries, e.g., Japan, England, and 
the U.S. These findings are consistent with the “cumulative disadvantage” hypothesis in the 
health disparities literature (House et al. 2005). This also indirectly suggests a fixed frailty 
across the life span is relatively unlikely as a fixed frailty and selective mortality will reduce 
the mortality variation in old age (Manton et al. 1981). This also suggests that, although 
mortality selection may operate throughout the life course, this mechanism is not strong 
enough to reverse the overall increasing mortality variation over ages.
Net of age and period effects, we found that the estimated residual mortality variations were 
relatively flat for cohorts born before the 20th century but significantly declined across 
cohorts born after the early 20th century. These findings suggest that when major causes of 
death were shifted from infectious diseases to chronic disease in the late 19th and early 20th 
century this cohort pattern emerged. These findings are generally consistent with Myers and 
Manton (1984a)'s finding that mortality dispersion with all deaths included is negatively 
correlated with the level of life expectancy. While the Myers and Manton study pertains to a 
period pattern, our finding distinguishes the period and cohort components of the change. 
The substantial decline we found for most recent cohorts may also result from the relative 
young age of these cohorts. These findings support the prediction of increasing prevalence of 
robust individuals in younger cohorts from technophysio evolution theory and cohort 
morbidity phenotype theory. All in all, these findings suggest that, although frail individuals 
are more likely to survive into adulthood in later cohorts due to socioeconomic development 
and medical advances, which possibly increases the heterogeneity among later cohorts, this 
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selective survival mechanism is not strong enough to reverse the overall reducing mortality 
variation trend across cohorts due to the continually increasing health capital and decreasing 
mortality rate at the population level (Zheng 2014).
With regard to period patterns of residual mortality variation, we found that, net of age and 
cohort effects, the variations continuously declined over much of the last two centuries but 
have substantially increased since 1980. Further analysis suggested the recent increases in 
the residual mortality variations are not due to increasing proportions of older adults in the 
population, which instead may explain the continual downward trend of mortality variation 
before 1980 as this indicator indirectly measures life expectancy. The reversal of the period 
trend in residual mortality variation after 1980 is also not due to the period trend in mortality 
rate as it is very flat across time periods after controlling for age and cohort effects as 
displayed in Figure 1. This also does not result from a disproportionate delay in deaths from 
degenerative and man-made diseases as mortality variation among population aged 65 and 
older continued declining after 1980 among these 15 countries except the U.S. We also 
found that residual mortality variation among young- and middle-aged adults (age 18 to 64) 
has increased in recent decades. In fact, the whole period trend in residual mortality 
variation is driven by the trend within young- and middle-aged adults. A re-emergence of 
infectious diseases such as HIV (Olshansky et al. 1997) and a widening mortality risk from 
these diseases across socioeconomic strata (Rubin et al. 2009) appears to be related to this 
trend, as these diseases tend to kill young- and middle-aged adults, but additional 
explanations should be explored in future research.
This study has several limitations. First, although the Human Mortality Database is 
considered to be of high quality, and has been widely used for cross-national and historical 
research on old-age mortality (Ho and Preston 2010; Wilmoth and Horiuchi 1999; Yashin et 
al. 2001), we cannot totally dismiss the possibility that our results may be biased by age 
misreporting in the death rates. Second, we only focus on more developed nations; therefore 
it is still unknown whether the patterns found in this paper could be generalized to less 
developed countries, especially given that they experienced demographic and epidemiologic 
transition at different timings and through different mechanisms.
In conclusion, using integrated HAPC-VFR models, this study yields some important 
findings. We find that residual mortality variation generally increases over the life course 
into the older ages, which supports the “cumulative advantage” theory and suggests that, 
although mortality selection may operate throughout life course, it does not reverse the 
overall increasing residual mortality variation over ages. We also find that residual mortality 
variation started declining in cohorts born after the early 20th century when the major causes 
of death shifted from infectious diseases to chronic illnesses. The declining residual 
mortality variation across cohorts was a result of continual mortality decline, which suggests 
although increasing survival may increase heterogeneity among younger cohorts, this force 
does not override the declining mortality rate to increase mortality variation. Net of age and 
cohorts effect, residual mortality variations continuously declined over much of the last two 
centuries but have substantially increased since 1980. The recent increases in residual 
mortality variations are not due to increasing proportions of older adults in the population, 
trends in mortality rates, or disproportionate delays in the deaths from degenerative and 
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man-made diseases, but rather due to increasing variations in young and middle-age adults. 
This is a somewhat surprising finding.
Many developed countries currently are at the fourth stage (the age of delayed degenerative 
diseases) of epidemiologic transition in which advances in medical technology and health 
care programs have further decreased mortality selection in younger ages, delayed the age at 
death, and improved survival at increasingly older ages (Wilmoth et al. 2000), which is 
supposed to increase heterogeneity within older populations (Engelman et al. 2010). But, in 
terms of mortality, our study does not find increasing residual variation at the older ages for 
more recent time periods or birth cohorts. One, however, should not infer that variations in 
other outcomes are not increased. For example, the variation in morbidity, disability, and 
functional impairment may increase due to the increasingly complex composition of older 
population, which is related to the morbidity compression or expansion debate (Fries 1980; 
Gruenberg 1977). Besides that, it is also important to investigate what factors may contribute 
to the increasing residual mortality variation in young and middle-age adults. The re-
emergence of infectious illness (e.g., HIV) and sedentary life style related risk factors (e.g., 
obesity) may certainly play a role in the increasing heterogeneity among young and middle-
age adults, but this new phenomenon merits further extensive attention and investigation. 
The public policy implications of the findings from this study are that, in order to reduce 
mortality variation and health disparities in the future, efforts should focus on relatively 
earlier stages of the life course rather than on the older ages.
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Figure 1. Variability in Predicted Mortality Rates across Age, Period and Cohort for Males and 
Females in 15 Populations
Note: Each line represents one country. The lowest lines in old age in the Age panel 
represent the U.S. The lines with the steepest decline in the Cohort panel represent Japan.
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Figure 2. Variability in Predicted Mortality Variations across Age for Males and Females in 15 
National Populations
Note: Each line represents one country.
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Figure 3. Variability in Predicted Mortality Variations across Cohorts for Males and Females in 
15 National Populations
Note: Each line represents one country.
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Figure 4. Variability in Predicted Mortality Variations across Time Periods for Males and 
Females in 15 National Populations
Note: Each line represents one country.
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Figure 5. Variability in Predicted Mortality Variations across Time Periods for Males and 
Females aged 65 and Older in 15 National Populations
Note: Each line represents one country. The bolded lines represent the U.S.
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Figure 6. Variability in Predicted Mortality Variations across Time Periods for Males and 
Females aged 18-64 in 15 National Populations
Note: Each line represents one country.
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Table 1
Summary of Data: Numbers of Mortality Rates, Time Periods, and Birth Cohorts for 
Each Country
Country Number of age-specific mortality rates Period Cohort
Australia 8091 1921-2007 1811-1989
Belgium 15717 1841-2009 1731-1991
Denmark 16275 1835-2009 1725-1991
England and Wales 15717 1841-2009 1731-1991
Finland 12276 1878-2009 1768-1991
France 18042 1816-2009 1706-1991
Iceland 15903 1838-2008 1728-1990
Italy 12741 1872-2008 1762-1990
Japan 5859 1947-2009 1837-1991
Netherlands 14880 1850-2009 1740-1991
New Zealand 10044 1901-2008 1791-1990
Norway 15252 1846-2009 1736-1991
Sweden 24180 1751-2010 1641-1992
Switzerland 12462 1876-2009 1766-1991
USA 6975 1933-2007 1823-1989
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Table 2
Estimated Regression Coefficients of the Proportion of Population Age 65 and Over on 
Mortality Variation by Country and Gender
Country Female Male
Australia
-4.53 *** -7.12 ***
Belgium
-13.01 *** -12.05 ***
Denmark
-12.17 *** -15.96 ***
England
-12.17 *** -12.22 ***
Finland
-11.94 *** -17.24 ***
France
-10.12 *** -8.37 ***
Iceland
-4.75 *** -31.53 ***
Italy
-16.79 *** -16.50 ***
Japan
-8.12 *** -5.02 ***
Netherlands
-3.91 *** -1.94 **
New Zealand
-6.22 *** -20.29 ***
Norway
-14.51 *** -13.87 ***
Sweden
-10.16 *** -18.75 ***
Switzerland
-24.45 *** -36.09 ***
USA
-8.20 ** -8.69 *
*indicates p<.05;
**indicates p<.01;
***indicates p<.001.
Popul Res Policy Rev. Author manuscript; available in PMC 2017 January 27.
